Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

Research finds compound in red wine beneficial for depression and anxiety

Staff Writer
Staff Writer 4 years ago
Updated 2020/04/27 at 6:31 PM
Share
SHARE

Resveratrol, a plant compound found in red wine, has shown to be beneficial in reducing stress, anxiety, and depression, according to a new study.

The compound provides therapeutic effects by inhibiting an enzyme called phosphodiesterase 4 (PDE4) associated with stressors in the brain. PDE4 reduces cyclic adenosine monophosphate in the body, leading to physical alterations in the brain.

In the past, studies have linked resveratrol to numerous health benefits. However, its relation to PDE4, which interacts with the stress hormone known as corticosterone, remains unclear. Corticosterone, produced in the cortex of the adrenal glands, is known to induce symptoms of depressive and anxiety disorders when excessive amounts of the hormone are found.

In a study on rodents, researchers observed behavior resembling depressive and anxiety disorders after uncovering PDE4 induced by high levels of corticosterone. In the findings, resveratrol demonstrated neuroprotective effects against corticosterone by blocking the expression of PDE4.


Overall, the study strengthens the notion of how its antidepressant effects might soon lead to new treatments.

“Resveratrol may be an effective alternative to drugs for treating patients suffering from depression and anxiety disorders,” Ying Xu, M.D., co-lead author of the study, concluded.

The study, also led by Xiaoxing Yin, Ph.D., a professor at Xuzhou Medical University, appeared in the journal Neuropharmacology.

You Might Also Like

New study explores test that can detect Alzheimer’s years before diagnosis

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

New research finds Alzheimer’s risk factors affect males and females very differently

Study establishes critical role in regulating excessive folding of gyri in brain

TAGGED: corticosterone, resveratrol, anxiety, depression
Staff Writer July 29, 2019
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Study strongly links smoking to peripheral artery disease
Next Article matcha-tea-anxiety-benefits Drinking Matcha tea could reduce your anxiety, study suggests

Recommended

Clinical

New study explores test that can detect Alzheimer’s years before diagnosis

1 Min Read
Clinical

Prenatal exposure to pollution may be linked to lower cognitive scores in infants

1 Min Read
Clinical

Researchers unveil new drug candidate to help treat adrenoleukodystrophy

1 Min Read
Clinical

New research finds Alzheimer’s risk factors affect males and females very differently

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?